在临床前和临床模型中预测结核病药物疗效,从体外数据中预测
Janice J N Goh1, Anu Patel1, Bernard Ngara1
1Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA, USA.
iScience
|March 4, 2025
概括
确定对Mycobacterium结核病药物最有效的实验室测试至关重要. 这项研究揭示了特定的测试,可以准确预测新的结核病药物在临床前和临床试验中的表现.
科学领域:
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
- 药物发现 药物发现 药物发现
背景情况:
- 有许多体外试验测试用于评估Mycobacterium结核病 (TB) 药物效率.
- 缺乏共识阻碍了选择临床相关的试验来预测药物疗效.
- 需要标准化方法来识别具有临床成功高潜力的结核病候选药物.
研究的目的:
- 为了确定一个在体外测试的签名,准确预测结核病药物的临床前疗效和早期临床结果.
- 建立一种可靠的方法来优先考虑候选药物,并优化结核病药物开发中的资源配置.
主要方法:
- 汇编了31个独特的实验室分析对10种现有的结核病药物的数据.
- 在实验室中比较EC50值与使用多项回归的小鼠模型中的药理动力学-药理动力学 (PK-PD) 模型衍生的EC50值.
- 使用五种新的结核病药物验证了表现最好的体外测试组合.
主要成果:
- 模仿巨细胞和泡巨细胞环境的测试签名最好用于预测急性和亚急性感染的疗效.
- 活体结核病例试验证明在预测慢性结核病感染的结果方面最有效.
- 随着时间的推移,模拟的小鼠细菌负担,使用预测的体内EC50值,与观察到的数据密切匹配 (在2倍之内).
结论:
- 这项研究确定了在临床上与评估Mycobacterium结核病候选药物相关的特定体外试验.
- 这些发现将有助于优先考虑成功的候选药物,从而节省资源并加速临床开发.
- 这项研究为选择结核病药物发现和开发中的预测分析提供了一个框架.
相关概念视频
Pulmonary Tuberculosis V
163
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
163
Pulmonary Tuberculosis IV
128
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
128
Pharmacokinetic Models: Comparison and Selection Criterion
36
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
36
Preclinical Development: Overview
4.2K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.2K
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
24
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
24
Pharmacokinetic Models: Overview
540
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
540


